Scientific and technological developments are making the field of diagnostic imaging a growth industry.
In 2007, the U.S. market for diagnostic imaging technologies was valued at more than $7 billion, and it is
expected to exceed $8 billion by 2011. There are several trends that companies must heed to enjoy success in
this market.
Get the Answers You Need to Shape Your Strategy
Diagnostic imaging comprises five major modalities: magnetic resonance imaging (MRI), ultrasound, X ray, computed tomography (CT), and nuclear medicine (i.e., single-photon-emission-computed tomography [SPECT] and positron-emission tomography [PET]).
What is the value of each of these fields today, and what are their growth prospects through 2011?
Opportunities for growth in the industry are varied.
One area is the development of hybrid modalities to combat competition and provide a more comprehensive and accurate diagnostic image.
What hybrids have been developed, and which ones are still at the development stage?
What are their respective advantages in the clinic?
The diagnostic imaging market faces two key challenges.
What are these challenges, and how might the industry address them?
Scope
The major diagnostic imaging modalities: magnetic resonance imaging (MRI), ultrasound, X ray, computed tomography (CT), and nuclear medicine (i.e., single-photon-emission-computed tomography [SPECT] and positron-emission tomography [PET]).
Opportunities for industry growth: improving clinical applications, developing hybrid modalities, advances in information technology, and exploiting nanotechnology.
The top three companies in the diagnostic imaging market: GE Healthcare, Siemens Healthcare Solutions, and Philips Medical Systems.
(0 items)
